Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Olfson

Showing results (481-490 of 687) with videos related to

Pageof 69
Sort By:
The American Journal of Psychiatry|January 23, 2020
U.S. Adults With Pain, a Group Increasingly Vulnerable to Nonmedical Cannabis Use and Cannabis Use Disorder: 2001-2002 and 2012-2013Deborah S Hasin, Dvora Shmulewitz, Magdalena Cerdá, et al.
General Hospital Psychiatry|May 11, 2005
Social anxiety disorder in primary careRaz Gross, Mark Olfson, Marc J Gameroff, et al.
JAMA Psychiatry|January 27, 2021
Association of Psychiatric Disorders With Mortality Among Patients With COVID-19Katlyn Nemani, Chenxiang Li, Mark Olfson, et al.
The Journal of Clinical Psychiatry|October 13, 2016
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia: Evaluating the EvidenceChristoph U Correll, Leslie Citrome, Peter M Haddad, et al.
The Journal of Clinical Psychiatry|January 10, 2017
Extent, Time Course, and Moderators of Antipsychotic Treatment in Youth With Mood Disorders: Results of a Meta-Analysis and Meta-Regression AnalysesChiara Cervesi, Su Young Park, Britta Galling, et al.
The Journal of Clinical Psychiatry|January 14, 2017
Generalizability of Neuroimaging Studies in 5 Common Psychiatric Disorders Based on the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)Carlos Blanco, Melanie M Wall, Martin A Lindquist, et al.
JAMA Psychiatry|February 21, 2019
Comparative Effectiveness of Adjunctive Psychotropic Medications in Patients With SchizophreniaT Scott Stroup, Tobias Gerhard, Stephen Crystal, et al.
Molecular Psychiatry|July 28, 2019
Psychiatric disorders and risk for multiple adverse outcomes: a national prospective studyCarlos Blanco, Melanie M Wall, Nicolas Hoertel, et al.
BMC Medical Research Methodology|August 28, 2012
Positive predictive value of a case definition for diabetes mellitus using automated administrative health data in children and youth exposed to antipsychotic drugs or control medications: a Tennessee Medicaid studyWilliam V Bobo, William O Cooper, C Michael Stein, et al.
The Journal of Clinical Psychiatry|June 19, 2008
Generalizability of clinical trial results for major depression to community samples: results from the National Epidemiologic Survey on Alcohol and Related ConditionsCarlos Blanco, Mark Olfson, Renee D Goodwin, et al.
Pageof 69

Showing results (481-490 of 687) with videos related to

Sort By:
Pageof 69
The American Journal of Psychiatry|January 23, 2020
U.S. Adults With Pain, a Group Increasingly Vulnerable to Nonmedical Cannabis Use and Cannabis Use Disorder: 2001-2002 and 2012-2013Deborah S Hasin, Dvora Shmulewitz, Magdalena Cerdá, et al.
General Hospital Psychiatry|May 11, 2005
Social anxiety disorder in primary careRaz Gross, Mark Olfson, Marc J Gameroff, et al.
JAMA Psychiatry|January 27, 2021
Association of Psychiatric Disorders With Mortality Among Patients With COVID-19Katlyn Nemani, Chenxiang Li, Mark Olfson, et al.
The Journal of Clinical Psychiatry|October 13, 2016
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia: Evaluating the EvidenceChristoph U Correll, Leslie Citrome, Peter M Haddad, et al.
The Journal of Clinical Psychiatry|January 10, 2017
Extent, Time Course, and Moderators of Antipsychotic Treatment in Youth With Mood Disorders: Results of a Meta-Analysis and Meta-Regression AnalysesChiara Cervesi, Su Young Park, Britta Galling, et al.
The Journal of Clinical Psychiatry|January 14, 2017
Generalizability of Neuroimaging Studies in 5 Common Psychiatric Disorders Based on the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)Carlos Blanco, Melanie M Wall, Martin A Lindquist, et al.
JAMA Psychiatry|February 21, 2019
Comparative Effectiveness of Adjunctive Psychotropic Medications in Patients With SchizophreniaT Scott Stroup, Tobias Gerhard, Stephen Crystal, et al.
Molecular Psychiatry|July 28, 2019
Psychiatric disorders and risk for multiple adverse outcomes: a national prospective studyCarlos Blanco, Melanie M Wall, Nicolas Hoertel, et al.
BMC Medical Research Methodology|August 28, 2012
Positive predictive value of a case definition for diabetes mellitus using automated administrative health data in children and youth exposed to antipsychotic drugs or control medications: a Tennessee Medicaid studyWilliam V Bobo, William O Cooper, C Michael Stein, et al.
The Journal of Clinical Psychiatry|June 19, 2008
Generalizability of clinical trial results for major depression to community samples: results from the National Epidemiologic Survey on Alcohol and Related ConditionsCarlos Blanco, Mark Olfson, Renee D Goodwin, et al.
Pageof 69